Investigation of the Prognostic Value of TNF-α Gene Polymorphism among Patients Treated with Inflixi...
Investigation of the Prognostic Value of TNF-α Gene Polymorphism among Patients Treated with Infliximab, and the Effects of Infliximab Therapy on TNF-α Production and Apoptosis
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland
Subjects
More information
Scope and Contents
Contents
Objectives: Infliximab, a chimeric anti-tumor necrosis factor (TNF) antibody, is highly effective for the treatment of Crohn’s disease (CD) and rheumatoid arthritis (RA). Our experiments focused on RA and CD patients receiving infliximab. Since cytokine production is largely determined by genetic factors, the promoter polymorphisms of TNF-α were ex...
Alternative Titles
Full title
Investigation of the Prognostic Value of TNF-α Gene Polymorphism among Patients Treated with Infliximab, and the Effects of Infliximab Therapy on TNF-α Production and Apoptosis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_karger_primary_80062
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_karger_primary_80062
Other Identifiers
ISSN
1015-2008
E-ISSN
1423-0291
DOI
10.1159/000080062
